[logo] HealthTree Foundation
more_vert

What’s New in AML: Menin Inhibitors Explained

What’s New in AML: Menin Inhibitors Explained image

What’s New in AML: Menin Inhibitors Explained

Webinar
event Feb 05, 2026 / 01:00PM - 02:00PM EST
link icon facebook logo X logo linkedin logo reddit logo email icon
videocam
Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

Menin inhibitors are a newly approved class of treatments for certain types of AML. In this AML patient webinar, Dr. Eunice Wang will explainswhat menin inhibitors are, review recent approvals, and discuss important differences between the available options, so you can better understand where they may fit into your AML care.

 

Schedule & Agenda

The panelist Mary Arnett
1:00 PM
Introduction
Mary Arnett

Mary introduces the agenda for the event and featured speaker Dr. Eunice Wang

The panelist Eunice Wang, MD
1:05 PM
Presentation
Eunice Wang, MD

Dr. Wang will talk about menin inhibitors.

The panelist Audience
1:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Mary Arnett
Mary Arnett
Salt Lake City, UT

Mary joined HealthTree in 2022. She is now the AML & MDS Patient Engagement Manager. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.

Read Bio
The panelist Eunice Wang, MD
Eunice Wang, MD
Buffalo, NY

Dr. Eunice Wang is the Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center. Dr. Wang’s clinical research focuses on the development of early stage clinical trials for acute leukemias (AML, ALL) and myeloproliferative disorders. Her translational research interests involve the development of novel biological therapies targeting the bone marrow microenvironment for myeloid malignancies. Dr. Wang has authored/co-authored over 90 peer-reviewed articles, multiple book chapters, and editorials. In addition to her research, Dr. Wang maintains an active clinical practice.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Treatments & Drugs group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the Latest Acute Myeloid Leukemia Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.

Together we care.

Together we cure.

3x Faster.

Join our year-end match and help us reach $2 million for blood cancer research!